NEOGEN-D in each tsp recalled over manufacturing violations
- Recall date
- June 21, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharma-Natural Inc. recalls NEOGEN-D (Dextromethorphan HBr, 30 mg; Guaifenesin, 200 mg; Phenylephrine HCl, 7.5 mg) in each 5 mL tsp, Raspberry Flav…
- Recall number
- D-1506-2019
- FDA classification
- Class II
- Brand / firm
- Pharma-Natural Inc.
- Sold / distributed
- Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.
Why it was recalled
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
NEOGEN-D (Dextromethorphan HBr, 30 mg; Guaifenesin, 200 mg; Phenylephrine HCl, 7.5 mg) in each 5 mL tsp, Raspberry Flavor, 16 fl oz (473 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-699-16.
Get recall alerts
Free email alert whenever Pharma-Natural Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharma-Natural Inc.